Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

Plain-English summary

Apollo Care, LLC is voluntarily recalling 37,546 vials of Semaglutide 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vials. The recall is due to the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material. The affected product is distributed nationwide within the U.S.

The recall covers specific lots with expiration dates ranging from November 2026 to May 2027. The NDC for the product is 71170-821-01. The agency has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.

Consumers and healthcare providers should stop using the affected vials and contact their healthcare provider or the recalling firm for further instructions. The source text does not report any specific illnesses or injuries associated with this recall.

The recalled product

Product

SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01

Manufacturer

Apollo Care, LLC

Category

Drug — Injectable Medication

Hazard

• particulate-matter
• contamination

Affected units

37,546

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Distribution

Related recalls